6-Thioguanine
Sponsors
Rutgers, The State University of New Jersey, Goethe University, Therapeutic Advances in Childhood Leukemia Consortium, M.D. Anderson Cancer Center, Memorial Sloan Kettering Cancer Center
Conditions
Acute Lymphoblastic LeukemiaAcute Lymphocytic LeukemiaAdult Acute Lymphocytic LeukemiaAnaplastic Glioma of BrainBrain CancerGlioblastoma MultiformeHodgkin's DiseaseLangerhans Cell Histiocytosis
Phase 1
ABT-751 With Chemotherapy for Relapsed Pediatric ALL
TerminatedNCT00439296
Start: 2006-05-22End: 2009-09-23Updated: 2021-03-17
Study of 6-Thioguanine in Combination With 6-Mercaptopurine During Maintenance Therapy of Childhood Lymphoma
WithdrawnNCT02141100
Start: 2014-07-31End: 2016-10-31Updated: 2016-10-07
Phase 2
CINJALL: Treatment for Children With Acute Lymphocytic Leukemia
CompletedNCT00176462
Start: 2001-02-28End: 2008-09-30Updated: 2014-06-09
6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
CompletedNCT00504660
Start: 2003-09-30End: 2010-08-31Updated: 2012-01-11
Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)
CompletedNCT00587873
Start: 1994-03-31End: 2009-06-30Updated: 2009-06-12
Study of Sequential Administration of Oral 6-Thioguanine After Methotrexate in Patients With LCH
CompletedNCT00588536
Start: 1995-01-31End: 2009-06-30Updated: 2015-05-04